$26.46
-0.25-0.95%
Last update: Aug 24, 3:24 PM
Nurix Therapeutics Inc Earnings Estimates
NRIXNASDAQ
Nurix Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:NRIX
Nurix Therapeutics (NRIX) is scheduled to report Q3 earnings on October 8, 2026. Analysts estimate EPS of $3.98 and quarterly revenue of $411.48M.
In the most recent quarter (Q2), Nurix Therapeutics reported EPS of $-0.81, missing estimates of $-0.72 by 0.13%. Revenue came in at $9.04M, missing the estimate of $15.09M by 0.4%.
Nurix Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Nurix Therapeutics has averaged an EPS surprise of 0.11% and a revenue surprise of 0.4%.
Earnings Date
Oct 8
EPS Estimate
$3.980
Quarterly Revenue Estimate
$411.48M
Annual Revenue
$36.77M
as of May 31
Nurix Therapeutics Earnings History
Analyze the earnings history of Nurix Therapeutics using advanced sorting and filters.
Nurix Therapeutics (NRIX) Earnings Per Share
The chart below shows Nurix Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Nurix Therapeutics (NRIX) Revenue
The chart below shows Nurix Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Nurix Therapeutics (NASDAQ:NRIX) reporting earnings?
Nurix Therapeutics (NRIX) is scheduled to report earnings on October 8, 2026. The last reported earnings were for reported on July 9, 2026 for Q2.
What were the latest earnings per share (EPS) for Nurix Therapeutics (NASDAQ:NRIX)?
The Actual EPS was $-0.81, which missed the estimate of $-0.72.
What were Nurix Therapeutics’s (NASDAQ:NRIX) revenues?
The Actual Revenue was $9.04M, which missed the estimate of $15.09M.
